1. Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis
   Chien-Hsiu Li et al, 2021, Biomedicines CrossRef
2. Extracellular Matrix Signals as Drivers of Mitochondrial Bioenergetics and Metabolic Plasticity of Cancer Cells During Metastasis
   Félix A. Urra et al, 2021, Front. Cell Dev. Biol. CrossRef
3. Preclinical Solid Tumor Models to Study Novel Therapeutics in Brain Metastases
   Mohini Singh et al, 2021, Current Protocols CrossRef
4. ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma
   Chongchang Zhou et al, 2022, Clinical Laboratory Analysis CrossRef
5. Identification of Master Regulators Driving Disease Progression, Relapse, and Drug Resistance in Lung Adenocarcinoma
   Qiong Xu et al, 2022, Front. Bioinform. CrossRef
6. Integrinβ3 mediates the protective effects of soluble receptor for advanced glycation end-products during myocardial ischemia/reperfusion through AKT/STAT3 signaling pathway
   Xuejie Han et al, 2022, Apoptosis CrossRef
7. The EDN1/EDNRA/β‑arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylation
   Yeo-Jin Lee et al, 2022, Int J Oncol CrossRef
8. The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents
   Huong Chi Mai Tran et al, 2024, Thrombosis Research CrossRef